Browsing by Subject "Rhodococcus equi"
Now showing items 1-6 of 6
-
Antibodies Targeting Poly-N-Acetyl Glucosamine Protect Against the Intracellular Pathogen, Rhodococcus Equi
(2018-11-21)Rhodococcus equi is a facultative intracellular pathogen that causes pyogranulomatous pneumonia in foals <6 months of age. Why foals are highly susceptible to R. equi is unknown. R. equi pneumonia is a leading cause of ... -
Epidemiology of Airborne Virulent Rhodococcus equi at Horse Breeding Farms
(2012-02-14)Rhodococcus equi causes severe pneumonia, resulting in disease and sometimes death of foals. Infection is thought to occur by inhalation of dust contaminated with virulent R equi. A recent study of 3 horse breeding farms ... -
Expression of Virulence-Associated Protein A (VapA) of Rhodoccocus equi by infected macrophages.
(2011-04-25)Rhodococcus equi is a Gram-positive bacterium known to cause disease because of its ability to survive and replicate inside macrophages. Macrophages also act as antigen-presenting cells: peptides from bacteria that have ... -
Genetic susceptibility to Rhodococcus equi
(2015)Rhodococcus equi pneumonia is a major cause of morbidity and mortality in neonatal foals. Much effort has been made to identify preventative measures and new treatments for R. equi with limited success. With a growing focus ... -
Investigating Genetic Susceptibility to Rhodococcus equi
(2015-12-10)Rhodococcus equi causes pneumonia and extrapulmonary disorders in foals and other immunocompromised animals including people. Although exposure to virulent R. equi is widespread in the environment of foals, only a small ... -
The susceptibility patterns of eight antimicrobial agents for potential treatment of Rhodococcus equi pneumonia in foals
(Texas A&M University, 2005-02-17)Rhodococcus equi is a common cause of severe pneumonia in foals, and is an opportunistic pathogen in immunocompromised humans. In combination, erythromycin and rifampin are the most commonly used antimicrobials in treating ...